You lose fat from everywhere, including subcutaneous depots
Common side effects: nausea, vomiting, diarrhoea, indigestion, stomach pain, bloating, heartburn, reflux, constipation, burping, and gastritis Low blood sugar (hypoglycaemia): more likely if used with insulin or sulfonylureassymptoms include sweating, a rapid heartbeat, hunger, dizziness, fatigue, or confusion Serious but less common side effects: severe allergic reactions (e.g
manageable with dose escalation Scientific and Media Impact The Phase 2 results generated substantial attention in both the scientific community and mainstream media
They also slow gastric emptying, leading to reduced appetite and potential weight loss
PATIENTS STOP WEGOVY, OTHER WEIGHT LOSS-RELATED DRUGS SHORTLY AFTER STARTING, DOCTORS SAY The FDA has issued warnings about compounded drug products containing semaglutide or semaglutide salts
Edibles provide a discrete, smoke-free experience